OncoCyte Corp (OCX) — Cash Flow Reinvestment Rate
Latest as of September 2014:
1.86x
OncoCyte Corp (OCX) has a Cash Flow Reinvestment Rate of 1.86x as of September 2014, reinvesting $13.00K (capex $13.00K ) from operating cash flow of $7.00K. Explore reinvestment intensity of OncoCyte Corp to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
1.86x
(Capex + Investments) / Operating CF
Total Reinvested
$13.00K
Capex + Investments
Operating Cash Flow
$7.00K
USD
Capital Expenditures
$13.00K
USD
Annual Cash Flow Reinvestment Rate for OncoCyte Corp (None–None)
Year-by-year capital reinvestment analysis for OncoCyte Corp. For live market cap and broader valuation context, see OncoCyte Corp market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow